pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    amoxicillin + vonoprazan fumarate
    Voquezna Dual Pak (amoxicillin + vonoprazan fumarate)
    Helicobacter pylori Infections$PHAT Phathom Pharmaceuticals, Inc.6 cat
  • Marketed
    axitinib SR
    AXPAXLI (axitinib)
    Wet (Neovascular / Exudative) Macular Degeneration$OCUL OCULAR THERAPEUTIX, INC1 cat
  • Marketed
    (doravirine + lamivudine + tenofovir disoproxil fumarate)
    Delstrigo ((doravirine + lamivudine + tenofovir disoproxil fumarate))
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Merck Sharp & Dohme Corp (Inactive)
← prev
page 30 of 231
next →
131
Pain89
Neurology1
7 cat
  • Marketed
    doravirine
    Pifeltro (doravirine)
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Merck Sharp & Dohme Corp (Inactive)6 cat
  • Marketed
    JUBBONTI
    JUBBONTI (DENOSUMAB-BBDZ)
    no indication Sandoz Inc3 cat
  • Marketed
    OSENVELT
    OSENVELT (DENOSUMAB-BMWO)
    no indication Celltrion Inc3 cat
  • Marketed
    AUKELSO
    AUKELSO (DENOSUMAB-KYQQ)
    no indication$HCWB HCW Biologics Inc.2 cat
  • Marketed
    BILPREVDA
    BILPREVDA (DENOSUMAB-NXXP)
    no indication Shanghai Henlius Biotech Inc2 cat
  • Marketed
    CONEXXENCE
    CONEXXENCE (DENOSUMAB-BNHT)
    no indication Fresenius Kabi USA LLC2 cat
  • Marketed
    ENOBY
    ENOBY (DENOSUMAB-QBDE)
    no indication$LBRX LB PHARMACEUTICALS INC2 cat
  • Marketed
    denosumab biosimilar
    Jubereq (denosumab-dssb)
    Post Menopausal Osteoporosis Luye Pharma Group Ltd2 cat
  • Marketed
    OSVYRTI
    OSVYRTI (denosumab-desu)
    no indication$ABVC ABVC BIOPHARMA, INC.1 cat
  • Marketed
    DEXTROAMPHETAMINE SULFATE
    DEXTROAMPHETAMINE SULFATE
    Attention Deficit Hyperactivity Disorder (ADHD) Sunrise Pharmaceutical Inc8 cat
  • Marketed
    infliximab biosimilar
    Renflexis (infliximab-abda)
    Pulmonary Sarcoidosis Xentria Inc6 cat
  • Marketed
    lebrikizumab
    Ebglyss (lebrikizumab)
    Atopic Dermatitis (Atopic Eczema) Lilly USA LLC3 cat
  • Marketed
    glofitamab
    Columvi (glofitamab-gxbm)
    Mantle Cell Lymphoma F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    LOMUSTINE
    LOMUSTINE
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Carnegie Pharmaceuticals LLC1 cat
  • Marketed
    Renvela
    Renvela (sevelamer carbonate)
    Hyperphosphatemia In Chronic Kidney Disease Sanofi-Aventis US LLC1 cat
  • Marketed
    (empagliflozin + linagliptin)
    Glyxambi ((empagliflozin + linagliptin))
    Type 2 Diabetes Boehringer Ingelheim Corp21 cat
  • Marketed
    (empagliflozin + metformin hydrochloride ER)
    Synjardy XR ((empagliflozin + metformin hydrochloride))
    Type 2 Diabetes Boehringer Ingelheim Corp15 cat
  • Marketed
    ANASTROZOLE
    ANASTROZOLE
    Hormone Sensitive Breast Cancer Stason Pharmaceuticals Inc11 cat
  • Marketed
    LEFLUNOMIDE
    LEFLUNOMIDE
    Rheumatoid Arthritis Abhai Inc8 cat
  • Marketed
    (empagliflozin + linagliptin + metformin hydrochloride) ER
    Trijardy XR ((empagliflozin + linagliptin + metformin hydrochloride))
    Type 2 Diabetes Boehringer Ingelheim Corp7 cat
  • Marketed
    NEOSTIGMINE METHYLSULFATE
    NEOSTIGMINE METHYLSULFATE
    no indication$AMPH Amphastar Pharmaceuticals, Inc.3 cat
  • Marketed
    revumenib citrate
    Revuforj (revumenib citrate)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$SNDX Syndax Pharmaceuticals Inc2 cat
  • Marketed
    DESIPRAMINE HYDROCHLORIDE
    DESIPRAMINE HYDROCHLORIDE
    Depression Validus Pharmaceuticals LLC7 cat
  • Marketed
    mirikizumab
    Omvoh (mirikizumab-mrkz)
    Ulcerative Colitis Eli Lilly and Co5 cat
  • Marketed
    belantamab mafodotin
    Blenrep (belantamab mafodotin-blmf)
    Refractory Multiple Myeloma GlaxoSmithKline LLC1 cat
  • Marketed
    clonidine hydrochloride
    Clonidine Hydrochloride
    Hypertension Frontida Biopharm Inc1 cat
  • Marketed
    ESMOLOL HYDROCHLORIDE
    ESMOLOL HYDROCHLORIDE
    Infantile Hemangiomas Arkayli Biopharma Inc33 cat